Lepu Biopharma Co., Ltd. (2157.HK) HKSE

9.49

-0.27(-2.77%)

Updated at August 18 04:09PM

Currency In HKD

Valuation

Market Cap4.16B
Enterprise Value4.61B
P/E Ratio-36.24
PEG Ratio0.33
Price/Sales Ratio42.75
Price/Book Ratio21.21
Enterprise/Revenue43.97
Enterprise/EBITDA-51.01

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-1.12
Operating Margin-1.06

Management Effectiveness

Return On Assets-0.18
Return On Equity-0.51

Income Statement

Revenue367.79M
Revenue/Share0.21
Gross Profit292.97M
EBITDA-311.94M
Net Income-411.38M
Diluted EPS-0.24

Balance Sheet

Total Cash464.91M
Total Cash/Share0.27
Total Debt850.16M
Total Debt/Equity1.21
Current Ratio0.62
Book Value Per Share0.4

Price History

52-Week Change220.61
52-Week High10.38
52-Week Low2.16
Moving Average 50 Days6.78
Moving Average 200 Days4.21

Statistics

Average Volume33.59M
Shares Outstanding1.8B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A